Dr. Jamy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816
Education & Training
University of Tennessee (Nashville)Residency, Internal Medicine, 2013 - 2016
Aga Khan Medical CollegeClass of 2012
Certifications & Licensure
AL State Medical License 2016 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia Start of enrollment: 2022 Jun 01
Roles: Contact
- Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study Start of enrollment: 2024 May 02
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 10 citationsInduction of Acute Myeloid Leukemia with Idarubicin, Cytarabine and CladribineEric Wiedower, Omer Jamy, Michael Gary Martin
Anticancer Research. 2015-11-01 - 99 citationsPost-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.Javier Bolaños-Meade, Mehdi Hamadani, Juan Wu, Monzr M Al Malki, Michael J Martens
The New England Journal of Medicine. 2023-06-22 - 1 citationsDonor types and outcomes of transplantation in myelofibrosis: a CIBMTR study.Tania Jain, Noel Estrada-Merly, M Queralt Salas, Soyoung Kim, Jakob DeVos
Blood Advances. 2024-08-27
Abstracts/Posters
- Genomic Landscape of Sex Disparities in Multiple MyelomaOmer Jamy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- A phase II study of myeloablative allogeneic hematopoietic stem cell transplantation (aHSCT) for acute lymphoblastic leukemia (ALL) in older patients using fludarabine...ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrel...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
SELLAS Life Sciences to Host Virtual Expert Panel Discussion on GFH009 in Acute Myeloid LeukemiaMay 16th, 2023- SELLAS Life Sciences to Host Key Opinion Leader Webinar on Galinpepimut-S Acute Myeloid Leukemia ProgramJanuary 19th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
